Filter Results
6541697 results
Time evolution of melt pool / plasma region shown together with time-dependent phase changes determined from interference fringence: "diff phase overlay.mp4" The color map goes from -2Pi (blue) to +14Pi (red), see "image sequence with legends.jpg"
Data Types:
  • Image
  • Video
  • Dataset
Raw mass spec data and Data S1-4
Data Types:
  • Image
  • Tabular Data
  • Dataset
This dataset is described in the manuscript "Gene architecture and sequence composition underpin selective dependency of long RNAs on components of the nuclear export pathway". See Methods section in the paper, particularly "Western blot".
Data Types:
  • Image
  • Dataset
Supplement 1: Report of Cases Seven patients were prescribed dupilumab for chronic recalcitrant presumed AD (cases 1-4), or as an off-label treatment for patients with MF and severe pruritus (cases 5-7). In all 7 patients, the standard dosing regimen for dupilumab was followed (600mg loading dose, followed by 300mg every 2 weeks subcutaneously). Case vignettes and photographs found below.
Data Types:
  • Image
  • Dataset
  • Document
Here are the results in a paper entitled "Characterization of the 2008 phreatomagmatic eruption of Okmok from ArcticDEM and InSAR: deposition, erosion, and deformation" submitted to JGR Solid Earth in 2020. The main revision compared to version 1: This revision does not use one DEM (acquired on 15 May 2016) that was partly contaminated by clouds in the north flank of Ahmanilix. This revision mostly improves the result of the elevation change rate (rate.tif), but it also slightly changes the elevation change data and its corresponding uncertainties. It includes the 2-m resolution surface elevation change of the 2008 Okmok eruption (Fig. 3a in the paper) and the 2-m resolution post-eruptive elevation change rate map (Fig. 4), as well as the corresponding uncertainties (Fig. S3). It also includes the boundary of the proximal deposit field classified using a minimum elevation increase of 2 m, the boundary of large slope failure, and the shorelines of two lakes (Fig. 3a and S5) at different acquisition times. The GeoTIFF files can be viewed in free and open-source software QGIS, in Google Earth, or by Matlab using code https://github.com/ihowat/setsm_postprocessing/blob/master/readGeotiff.m. The shapefiles can be viewed in QGIS. Google Earth may not show some of the shapefiles well.
Data Types:
  • Image
  • Dataset
  • Document
  • File Set
Raw data and analysis scripts
Data Types:
  • Other
  • Software/Code
  • Image
  • Tabular Data
  • Dataset
  • Document
  • Text
  • File Set
A lemon (Le) leaf (Le) images dataset for aphids (Phid) detection. It includes 665 files with annotations regarding objects (leaves) and state (healthy and aphids presence).
Data Types:
  • Software/Code
  • Image
  • Tabular Data
  • Dataset
  • File Set
Data for Figure 1, 2, 4, 6, 8 and 10 for a paper to be submitted in data in brief journal. These data describe the values in spectroscopic analysis which are Fourier transform infra red (FTIR), UV-Vis spectrophotometer, Nuclear magnetic resonance (NMR).
Data Types:
  • Other
  • Software/Code
  • Image
  • Tabular Data
  • Dataset
  • Document
  • Text
Raw trajectory data (GROMACS format) of 10 microseconds all atom molecular dynamics simulation of COVID-19 related SARS-CoV-2 dimeric main protease without ligand based on PDB 6LU7, were caclulated on a special purpose computer, MDGRAPE-4A, at RIKEN BDR, JAPAN. We can observe relaxation dynamics and fluctuations of the dimeric protease over the microseconds timescale. We hope that this raw data can help drug development efforts targeting the SARS-CoV-2 main protease. Preparation details and summaries will be submitted to "Data in Brief". More data might be added as new version or another dataset.
Data Types:
  • Other
  • Image
  • Tabular Data
  • Dataset
  • Text
Androgenetic alopecia global photographs pre- and post-treatment of with 5α-reductase inhibitors (5ARI). The images compared patients before and after 5ARI treatment. Patient 1(M/55): greatly increased improvement(seven-point score: 3) after 10 months of dutasteride treatment (0.5 mg/d); patient 2(M/61): moderately increased improvement(seven-point score: 2) after 1 year of finasteride treatment (1 mg/d); patient 3(M/65): slightly increased improvement(seven-point score: 1) after 6 months of dutasteride treatment (0.5 mg/d); patient 4(M/77): slightly increased improvement(seven-point score: 1) after 9 months of finasteride treatment (1 mg/d).
Data Types:
  • Image
  • Dataset
3